Cassava Sciences
Last update: January 5, 2021
Pharmaceuticals
United States (USA)
Its 10 main executivesRecent executive movements at Cassava Sciences
James Kupiec has joined the company as Chief Clinical Development Officer (news posted on January 5 2021).
Create an alert
to follow the executive moves at Cassava Sciences.
Cassava Sciences is one of the...
Most searched biographies at Cassava Sciences
- Remi Barbier, Chairman of the Board, President, Chief Executive Of...
- Patrick Scannon, Director
- Robert Gussin, Director
Click on an executive to view his biography >
Latest M&A news in Pharmaceuticals.
CVC Capital Partners has announced the acquisition of MedRisk (posted on Feb 24, 2021).
Jazz Pharmaceuticals has announced the acquisition of GW Pharmaceuticals (posted on Feb 4, 2021).
Nordic Capital has announced the acquisition of Advanz Pharma (posted on Feb 1, 2021).
Other contacts in the Pharmaceuticals industry
Latest news about Cassava Sciences
RSS NEWS FEEDS | Cassava Sciences, Inc.
Cassava Sciences’ Phase 2b Clinical Results in Alzheimer’s Selected as Late-Breaking News at CTAD 2020 | Cassava Sciences, Inc.
Cassava Sciences Announces Final Results of a Phase 2b Clinical Study of Sumifilam in Patients with Alzheimer’s Disease | Cassava Sciences, Inc.
Cassava Sciences to Hold Conference Call on Monday, September 14, 2020 at 8:30 am ET | Cassava Sciences, Inc.
Cassava Sciences to Present at H.C. Wainwright’s 22nd Annual Global Investment Conference | Cassava Sciences, Inc.
Cassava Sciences on Wikipedia, Google News & Yahoo Finance
Cassava Sciences on LinkedIn, Twitter & YouTube
Cassava Sciences has 2,041 competitors including Pfizer (United States (USA)), Johnson & Johnson (United States (USA)) and Roche (Switzerland).
Contact by email its executives including Nadav Friedmann 
Call Cassava Sciences at +1 512....
